Gene-editing tools such as CRISPR/Cas9 can be used to create isogenic cell lines, which can be further used to model a specific patient population. An isogenic cell line was created to model ...
Cells use small extracellular vesicles (sEVs) to transfer cargo and chemical messengers to neighboring and distant cells.
The Charcot-Marie-Tooth Association (CMTA) has announced a $300,000 investment in a groundbreaking gene editing project aimed ...
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
Genome editing offers the potential to create new therapies and advanced cell-line models for pharmaceutical discovery and production. The combination of Cyto-Mine and CRISPR– Cas9 should enable ...
Ryotaro Hashizume and colleagues used the CRISPR-Cas9 gene editing system to cleave the third chromosome in previously ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...
With a portfolio of 100+ patents worldwide, ERS' IP covers CRISPR/Cas9 applications across all cell types, including mammalian cells, bacteria, archaea, yeasts, and algae, as well as extracellular ...
2 BEs are fusion proteins made of a Cas9 enzyme that cleaves target DNA (nCas9 ... mutations in the FANCA gene in primary patient fibroblast and lymphoblastoid cell lines. Base editing restored FANCA ...
The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback